CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$2.77
-5.78%
Mkt Cap $600.86M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$11.00
Range $6.00 – $16.00
Implied Upside
+297.1%
Consensus $11.00 vs current $2.77
NASDAQ·Healthcare·Biotechnology
$2.77
-5.78%
Mkt Cap $600.86M
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$11.00
Range $6.00 – $16.00
+297.1%
Consensus $11.00 vs current $2.77